| Advisory Commission on Childhood Vaccines (ACCV) |
Advises and makes recommendations to the Secretary of HHS on issues relating to the operation of the Vaccine Injury Compensation Program (VICP) and ways to improve the VICP, including changing the Vaccine Injury Table, proposing legislation covering new and safer childhood vaccines, gathering information about vaccine-related injuries from Federal, State, and local immunization programs, and revising Vaccine Information Statements |
| Advisory Committee on Immunization Practices (ACIP) |
Advises the Secretary of HHS, the Assistant Secretary for Health, and the Director of CDC regarding the most appropriate selection of antigens and related agents for effective control of vaccine-preventable diseases in the civilian population. The committee provides advice for the control of diseases for which a vaccine is licensed in the United States. The guidance covers the appropriate use of the vaccine and may include recommendations for administration of immune globulin(s) and/or antimicrobial therapy shown to be effective in controlling the same disease. Guidance for the use of unlicensed vaccines may be developed if circumstances warrant. The ACIP also determines the vaccines and schedules included in the Vaccines for Children (VFC) Program |
| National Vaccine Advisory Committee (NVAC) |
Advises and makes recommendations to the ASH to achieve the optimal prevention of human infectious diseases through immunization and to achieve the optimal prevention against adverse reactions to vaccines |
| Vaccines and Related Biological Products Advisory Committee (VRBPAC) |
Reviews and evaluates data concerning the safety, effectiveness, and appropriate use of vaccines and related biological products that are intended for use in the prevention, treatment, or diagnosis of human diseases, and any other product for which the FDA has regulatory responsibility. The committee also considers the quality and relevance of FDA’s research program, which provides scientific support for the regulation of these products and makes appropriate recommendations to the Commissioner of FDA |
| National Preparedness and Response Science Board (NPRSB, formerly the National Biodefense Science Board, NBSB) |
Advises the Assistant Secretary for Preparedness and Response within HHS and the Secretary of HHS on preventing, preparing for, and responding to adverse health effects of emergencies |
| National Advisory Allergy and Infectious Diseases Council (NAAIDC) |
Advises and makes recommendations to the Director of the NIH on matters relating to research activities and functions of the National Institute of Allergy and Infectious Diseases (NIAID) and includes an AIDS Vaccine Research Subcommittee |
